Get the Stockscreener App
10.61
0.09%
0.010
After Hours:
10.61
Drugs Made In America Acquisition Corp stock is traded at $10.61, with a volume of 245.
It is up +0.09% in the last 24 hours and up +0.47% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.60
Open:
$10.61
24h Volume:
245
Relative Volume:
0.00
Market Cap:
$257.58M
Revenue:
-
Net Income/Loss:
$5.94M
P/E Ratio:
59.88
EPS:
0.1772
Net Cash Flow:
$-539.20K
1W Performance:
+0.09%
1M Performance:
+0.47%
6M Performance:
+2.71%
1Y Performance:
+4.69%
1-Day Range:
$10.61
$10.61
1-Week Range:
$10.59
$10.61
52-Week Range:
$10.13
$10.61
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.61 | 257.34M | 0 | 5.94M | -539.20K | 0.1772 |
LION
Lionsgate Studios Corp
|
14.35 | 4.14B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.32 | 2.54B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
31.78 | 1.41B | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.06 | 641.46M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.19 | 595.10M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
NXRT Q1 2026 Earnings: Narrower-Than-Expected Loss, Stock Edges LowerBanking Earnings Report - thelegaladvocate.com
Eli Lilly and Company - Britannica
DMIIU Units Edge Lower by 0.44% as Price Holds Near $10.11 Amid Quiet TradingVWAP Breakout - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Near Trust Value Amid Low VolatilityInstitutional Sentiment - thelegaladvocate.com
Huadi International Group (HUDI) Faces Steep Decline, Testing Key Support at $1.0Turnaround Stocks - thelegaladvocate.com
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
PTACU|Patriot Acquisition Units (Proposed)|Price:9.950|Chg%:-0.01 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
MMCAP International Inc. SPC's Drugs Made In America Acquisition II Corp(DMII) Holding History - GuruFocus
Trump-Xi Summit: The 3 Big Takeaways from Historic Meeting in BeijingReturn On Equity - The Legal Advocate
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
TradingKey - TradingKey
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
GUACU|Berto Acquisition II Units (Proposed)|Price:10.030|Chg%:-0.01 - TradingKey
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
Mercuria Capital Strategies, LLC's Drugs Made In America Acquisition Corp(DMAA) Holding History - GuruFocus
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
QLEP_u|Quantum Leap Acquisition Units (Proposed)|Price:10.006|Chg%:0.01 - TradingKey
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Overnight Profile - thelegaladvocate.com
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
The top 20 pharma companies by 2025 revenue - Fierce Pharma
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):